Clinical Trials
Benign Hematology
ITP
A Phase I/II Study of Immunotherapy with Humanized Anti-CD20 Antibody, IMMU-106 (hA20), in Adult Patients with Chronic Immune Thrombocytopenic Purpura.
- Principal Investigator: Thomas M. Cosgriff, MD, FACP
Cancer Care of Louisiana / Specialists in Cancer and Blood Disorders / cancercareofla.com / Careers / Home
Clinical Trials Involve Years
of Research & Experiments
Carefully conducted clinical trials are the fastest and safest ways to find treatments that work in people and to improve health.
